Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC04937 |
| Type | Targeted Mutation |
| Species | Mus musculus |
| Strain name | B6;129S4-Atrx<tm1Enl> |
| Former Common name | B6-Atrx KO (ATRX<deltaE2>) |
| H-2 Haplotype | |
| ES Cell line | J1 [129S4/SvJae] |
| Background strain | |
| Appearance | |
| Strain development | Developed by Hideyuki Beppu and En Li, Massachusetts General Hospital, Harvard Medical School. |
| Strain description | |
| Colony maintenance | Heterozygote (female), Hemizygote (male) x Wild-type [C57BL/6JJmsSlc] |
| References | Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain. Norifumi Shioda, Hideyuki Beppu, Takaichi Fukuda, En Li, Isao Kitajima, Kohji Fukunaga J. Neurosci., 31, 346-358 (2011). 21209221Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice. Tatsuya Nogami, Hideyuki Beppu, Takashi Tokoro, Shigeki Moriguchi, Norifumi Shioda, Kohji Fukunaga, Toshihisa Ohtsuka, Yoko Ishii, Masakiyo Sasahara, Yutaka Shimada, Hisao Nishijo, En Li, Isao Kitajima Hippocampus, 21, 678-687 (2011). 20865721 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| Atrx MGI:103067 | ATRX, chromatin remodeler | X | Atrx<tm1Enl> MGI:4888669 | targeted mutation 1, En Li | |||
| IRES | internal ribosomal entry site (EMCV) | X | |||||
| lacZ | beta-galactosidase (E. coli) | X | |||||
| neo | neomycin resistance gene (E. coli) | X | |||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| Donor DNA | Mouse En-2 splicing acceptor, Encephalomyocarditis virus Internal ribosome-entry site, E. coli LacZ, E. coli Neomycin resistance gene, SV40 PolyA signal |
| Research application | Mouse Models for Human Disease Neurobiology Research |
| Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Hippocampus, 21, 678-687 (2011). The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and Massachusetts General Hospital (Boston, USA) and must obtain a prior written consent from the DEPOSITOR and Massachusetts Genearal Hospital. |
| Depositor | Hideyuki Beppu (University of Toyama) |
| Strain Status | Frozen sperm |
| Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
| Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
|---|
Yamaguchi K, Shioda N, Yabuki Y, Zhang C, Han F, Fukunaga K. SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome. Int J Mol Sci 19(9) (2018) 30231518 |
Shioda N, Yabuki Y, Yamaguchi K, Onozato M, Li Y, Kurosawa K, Tanabe H, Okamoto N, Era T, Sugiyama H, Wada T, Fukunaga K. Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome. Nat Med 24(6) 802-813(2018) 29785027 |